Effects of fermented, ropy, non-dairy, oat-based products on serum lipids and the faecal excretion of cholesterol and short chain fatty acids in germfree and conventional rats

Nutrition Research

Volumn 22, Issue 12, 2002, Pages 1461-1473

  Mårtensson, Olof ^a   Maite Duenas Chasco ^b   Irastorza, Ana ^b   Holst, Olle ^a   Rudling, Mats ^c   Norin, Elisabeth ^d   Midtvedt, Tore ^e   Öste, Rickard ^a  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

^e KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cholesterol; Exopolysaccharides; Germfree; Lactic acid bacteria; Non dairy; Oats

Indexed keywords

BETA GLUCAN; CARBOHYDRATE; CHOLESTEROL; COPROSTEROL; FAT; LIPID; POLYSACCHARIDE; PROTEIN; SHORT CHAIN FATTY ACID; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL FOOD; ARTICLE; BACTERIAL STRAIN; BLOOD SAMPLING; BODY WEIGHT; CONTROLLED STUDY; DIET; DIETARY FIBER; FECES; FEMALE; FERMENTATION; FOOD COMPOSITION; GERMFREE ANIMAL; LACTIC ACID BACTERIUM; LIPID BLOOD LEVEL; MALE; NONHUMAN; OAT; PRIORITY JOURNAL; RAT; RICE; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

ANIMALIA; AVENA;

EID: 0036932899     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0271-5317(02)00474-8     Document Type: Article

References (39)

1. Rosengren A, Hagman M, Wedel H, Willhelmsen L. Serum cholesterol and long-term prognosis in middle-aged men with myocardial infarction and angina pectoris: A 16-year follow-up of the Primary Prevention Study in Gbteborg, Sweden. Eur Heart J 1997;18:754-61.
2. Law MR, Wald NJ, WU T, Hackshaw A, Bailey A. Systemic underestimation of association between serum cholesterol concentration and ischaemic heart disease in observation studies: Data from BUPA Study. Br Med J 1994;308:363-66.
3. Agerholm-Larsen L, Raben A, Haulrik N, Hansen AS, Manders M, Astrup A. Effect of 8 week intake of probiotic milk products on risk factors for cardiovascular diseases. Eur J Clin Nutr 2000a;54:288-97.
4. Agerholm-Larsen L, Bell ML, Grunwald GK, Astrup A. The effect of a probiotic milk product on plasma cholesterol: A meta-analysis of short-term intervention studies. Eur J Clin Nutr 2000b;54:856-60.
5. Anderson JW, Bridges S-R. Hypocholesterolemic effects of oat bran in humans. In: Wood PJ, editor. Oat Bran. St. Paul: American Association of Cereal Chemists, US, 1993. p. 139-57.
6. Asp N-G, Mattsson B, Önning G. Variation in dietary fibre, β-glucan, starch, protein, fat and hull content of oats grown in Sweden 1987-1989. Eur J Clin Nutr 1992;46:31-7.
7. Lindahl L, Ahldén I, Öste R, Sjöholm I. Homogenous and stable cereal suspension and a method of making the same. 1997. United States Patent 5.686.123.
8. Önning G, Åkesson B, Öste R, Lundquist I. Effects of consumption of oatmilk, soya milk or cow's milk on plasma lipids and antioxidative capacity in healthy subjects. Ann Nutr Metabol 1998;42:211-20.
9. Mårtensson O, Öste R, Holst O. Lactic acid bacteria in an oat-based non-dairy milk substitute: Fermentation characteristics and EPS formation. Food Sci Technol/LWT 2000;33:525-30.
10. Mårtensson O, Andersson C, Andersson K, Öste R, Holst O. Formulation of an oat-based fermented product and its comparison to yoghurt. J Sci Food and Agri 2001;81:1413-21.
11. Mårtensson O, Öste R, Holst O. Texture promoting capacity and EPS formation by lactic acid bacteria in three different oat-based non-dairy media. Eur Food Res Technol 2002;214:232-36.
12. Nakajima H, Suzuki Y, Kaizu H, Hirota T. Cholesterol lowering activity of ropy fermented milk. J Food Sci 1992;6:1327-29.
13. Ruijssenaars HJ, Stingele F, Hartmans S. Biodegradability of food-associated extracellular polysaccharides. Curr Microbiol 2000;40:194-99.
14. Cummings JH, Englyst HN. Gastrointestinal effects of food carbohydrate. Am J Clin Nutr 1995;61(Suppl): 938S-45S.
15. Harris PJ, Feurgson LR. Dietary fibre: Its composition and role in protection against colorectal cancer. Mut Res 1993;290:97-110.
16. Gustafsson BE. The physiological importance of the colonic microflora. Scand J Gastroenterol 1982;77: 117-31.
17. nd Nestlé Nutrition Workshop in China May 11-15, 1997. Philadelphia: Lippincott-Raven Publishers, 1999. p. 79-96.
18. De Man JC, Rogosa M, Sharpe MEA. Medium for the cultivation of lactobacilli. J Appl Bacteriol 1960;23:130-35.
19. Gustafsson BE. Light weight stainless steel systems for rearing germfree animals. Ann NY Academ Sci 1959;78:17-28.
20. Festing MFW. International Index of Laboratory Animals. UK: University of Leicester, 1993.
21. Midtvedt A-C, Carlstedt-Duke B, Norin K-E, Saxerholt H, Midtvedt T. Development of five metabolic activities associated with the intestinal microflora of healthy infants. J Ped Gastroenterol Nutr 1988;7:559-66.
22. Midtvedt T., Bjørneklett A, Carlstedt-Duke B, Gustafsson BE. The influence of antibiotics upon microflora-associated characteristics in man and mammals. In: Wosmann BS, Pleasant JR, Pollard M, editors. Germfree Research: Microflora Control and its Application to the Biomedical Sciences. New York: Alan R. Liss Inc., 1985. p. 241-44.
23. Zijlstra JB, Beukma J, Wolthers BG, Byme BM, Groen A, Donkert L. Pretreatment methods prior to gas chromatography analysis of volatile fatty acids from faecal samples. Clin Chim Acta 1977;78:243-50.
24. Høverstad T, Fausa O, Bjøneklett A, Bøhmer T. Short-chain fatty acids in the normal human faeces. Scand J Gastroenterol 1984;19:375-81.
25. Danielsson H, Gustafsson B. On serum-cholesterol levels and neutral faecal sterols in germfree rats. Bile acids and steroids 59. Arch Biochem Biophys 1959;83:482-85.
26. Lovegrove JA, Clohessy A, Milton H, Williams C. Modest doses of β-glucan do not reduce concentration of potentially atherogenic lipoproteins. Am J Clin Nutr 2000;72:49-55.
27. Toba T, Nakajima H, Tobitani A, Adachi A. Scanning electron microscopic and texture studies on characteristic consistency of Nordic ropy sour milk. Int J Food Microbiol 1990;11:313-18.
28. Tamai Y, Yoshimitsu N, Watanabe Y, Kuwabara Y, Nagai S. Effects of milk fermented by culturing with various kind of lactic acid bacteria and a yeast on serum cholesterol level in rats. J Fermentation and Bioeng 1996;2:181-82.
29. Pulsani S, Rao DR. Whole body, liver and plasma cholesterol levels in rats fed Thermophilus Bulgaricus and Acidophilus milks. J Food Sci 1983;48:280-81.
30. Grunewald KK. Serum cholesterol levels in rats fed skim milk fermented by Lactobacillus acidophilus. J Food Sci 1982;47:2078-79.
31. Sadzikowski MR, Sperry JF, Wilkins TD. Cholesterol-reducing bacterium from human feces. Appl Environ Microbiol 1977;34:355-62.
32. Eyssen HJ, Paramentier GGC, Compemolle FC, Pauw G, Piessens-Denef M. Biohydrogeneration of sterols by Eubacterium ATCC 21.408-nova species. Eur J Biochem 1973;36:411-21.
33. Midtvedt T. Metabolism of endogenous substances. In: De Clerque E, editor. Frontiers in Microbiology. Dordrecht, The Netherlands: Martinus Nijhoff Publishers, 1987. p. 79-87.
34. Cummings JH. Short chain fatty acids in the human colon. Gut 1981;22:763-79.
35. Fleming SE, Arce DS. Volatile fatty acids: Their production, absorption, utilization and roles in human health. Clin Gastroenterol 1986;15:787-814.
36. Høverstad T, Midtvedt T. Short-chain fatty acids in intestinal content of germfree mice and rats. J Nutr 1986;116:1772-76.
37. Fleming SE, Choi SY, Fitch MD. Absorption of short-chain fatty acids from the rat cecum in vivo. J Nutr 1991;113:1613-26.
38. Maczulak A E, Wolin MJ, Miller TL. Amounts of viable anaerobes, methanogenes, and bacterial fermentation products in the faeces of rats fed high-fiber or fiber-free diets. Appl Environ Microbiol 1993;59: 657-62.
39. Spiller GA, Chemoff MC, Hill RAS, Gates JE, Nassar JJ, Shipley EA. Effect of purified cellulose, pectin, and a low-residue diet on faecal volatile fatty acids, transit time, and faecal weight in humans. Am J Clin Nutr 1980;33:754-75.